Cargando…

Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma

BACKGROUND: There have been limited treatment therapies for lung squamous cell carcinoma (LUSC). M6A-related genes may be the next therapeutic targets for LUSC. In this study, we explored the prognostic role and mutational characteristics of m6A-related genes in LUSC. METHODS: LUSC gene expression d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Chang, Shi, Xin, Qiu, Wenli, Huang, Zhenyu, Yu, Yan, Shen, Feng, Chen, Yumei, Pan, Xufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027321/ https://www.ncbi.nlm.nih.gov/pubmed/33842487 http://dx.doi.org/10.3389/fcell.2021.661792

Ejemplares similares

Diagnostic, Therapeutic, and Prognostic Value of the m(6)A Writer Complex in Hepatocellular Carcinoma
por: Gu, Zongting, et al.
Publicado: (2022)

The Prognostic Value and Immune Landscapes of a m(6)A/m(5)C/m(1)A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
por: Wang, Enhao, et al.
Publicado: (2021)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Comprehensive Analysis of the Effects of Genetic Ancestry and Genetic Characteristics on the Clinical Evolution of Oral Squamous Cell Carcinoma
por: Guo, Junfeng, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing
por: Fan, Chang, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
por: Liu, Jinhui, et al.
Publicado: (2022)

Comprehensive Analysis of Differentially Expressed Profiles of mRNA N6-Methyladenosine in Colorectal Cancer
por: Li, Na, et al.
Publicado: (2022)

Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Pterygium by MeRIP Sequencing
por: Jiang, Yaping, et al.
Publicado: (2021)

Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Role of TNF-α-induced m6A RNA methylation in diseases: a comprehensive review
por: Wang, Youlin, et al.
Publicado: (2023)

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021)

The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
por: Tan, Shuzhen, et al.
Publicado: (2021)

Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

The emerging role of m(6)A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review
por: Wang, Meiqi, et al.
Publicado: (2023)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

Transcriptome-Wide m6A Methylome and m6A-Modified Gene Analysis in Asthma
por: Sun, Deyang, et al.
Publicado: (2022)

Based on Molecular Subtypes, Immune Characteristics and Genomic Variation to Constructing and Verifying Multi-Gene Prognostic Characteristics of Colorectal Cancer
por: Gu, Lei, et al.
Publicado: (2022)

Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
por: Tan, Shuzhen, et al.
Publicado: (2022)

Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m(6)A RNA Methylation Regulators in Hepatocellular Carcinoma
por: Xu, Yangtao, et al.
Publicado: (2021)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
por: Cen, Shuyi, et al.
Publicado: (2021)

Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma
por: Cong, Peilin, et al.
Publicado: (2021)

A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing
por: Liao, Zhenyu, et al.
Publicado: (2023)

Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma
por: Luo, Na, et al.
Publicado: (2022)

Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators Expression Identify Distinct Molecular Subtypes of Myocardial Infarction
por: Shi, Xin, et al.
Publicado: (2021)

Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
por: Xie, Xiaona, et al.
Publicado: (2021)

Comprehensive Analysis of the Differential Expression and Prognostic Value of Histone Deacetylases in Glioma
por: Li, Jinwei, et al.
Publicado: (2022)

Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Feng, et al.
Publicado: (2021)

Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas
por: Gu, Yuan, et al.
Publicado: (2020)

Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma
por: Zhou, Chuqiao, et al.
Publicado: (2022)

The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma
por: Wang, Wenlong, et al.
Publicado: (2022)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma
por: Huang, Chao, et al.
Publicado: (2022)

m(6)A Reader: Epitranscriptome Target Prediction and Functional Characterization of N(6)-Methyladenosine (m(6)A) Readers
por: Zhen, Di, et al.
Publicado: (2020)

Immune Infiltrates of m(6)A RNA Methylation-Related lncRNAs and Identification of PD-L1 in Patients With Primary Head and Neck Squamous Cell Carcinoma
por: Feng, Zi-Yi, et al.
Publicado: (2021)

The m(6)A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m(6)A-modifying condition in the keloid
por: Lin, Can-Xiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uujqn5msudc5v5ete4tjhd1e4r